Andrew A Wagner
Overview
Explore the profile of Andrew A Wagner including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
100
Citations
1134
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ravi P, Kwak L, Acosta A, Rastogi S, Xie W, Abdelnaser A, et al.
Eur Urol
. 2025 Feb;
PMID: 39920004
Background And Objective: Long-term outcomes and the prognostic impact of the extent of residual disease after neoadjuvant therapy (NAT) with androgen deprivation therapy (ADT) and an androgen receptor pathway inhibitor...
2.
Pallauf M, Rezaee M, Elias R, Wlajnitz T, Fletcher S, Cheaib J, et al.
BJU Int
. 2025 Jan;
PMID: 39873312
Objective: To evaluate the association between tumour size and the growth rate (GR) of small renal masses (SRMs) in patients managed by active surveillance (AS). Materials And Methods: We queried...
3.
Newcomb L, Schenk J, Zheng Y, Liu M, Zhu K, Brooks J, et al.
JAMA
. 2024 May;
331(24):2084-2093.
PMID: 38814624
Importance: Outcomes from protocol-directed active surveillance for favorable-risk prostate cancers are needed to support decision-making. Objective: To characterize the long-term oncological outcomes of patients receiving active surveillance in a multicenter,...
4.
Estevez A, Kim P, Chang P, Wagner A
Eur Urol
. 2024 Apr;
85(6):e166.
PMID: 38570244
No abstract available.
5.
Cooke I, Heidar N, Mahmood A, Ahmad A, Jing Z, Stockle M, et al.
Urol Oncol
. 2024 Mar;
42(4):117.e17-117.e25.
PMID: 38429124
Objective: To assess the role of neoadjuvant chemotherapy (NAC) before robot-assisted radical cystectomy (RARC) for patients with variant histology (VH) muscle-invasive bladder cancer (MIBC). Methods: Retrospective review of 988 patients...
6.
Estevez A, Bansal U, Wagner J, Kaul S, Fleishman A, Bain P, et al.
Urology
. 2024 Feb;
186:83-90.
PMID: 38369197
Objective: To conduct a systematic review and meta-analysis to evaluate the association of a peritoneal interposition flap (PIF) with lymphocele formation following robotic-assisted laparoscopic radical prostatectomy (RALP) with pelvic lymph...
7.
Bansal U, Estevez A, Black J, Williamson T, Kaul S, Crociani C, et al.
J Endourol
. 2024 Feb;
38(5):499-504.
PMID: 38326749
Distinguishing between organ-confined disease and extraprostatic extension (EPE) is crucial for the treatment of patients with prostate cancer. EPE is associated with an increased risk of biochemical recurrence, positive surgical...
8.
McKay R, Xie W, Yang X, Acosta A, Rathkopf D, Laudone V, et al.
Cancer
. 2024 Jan;
130(9):1629-1641.
PMID: 38161319
Background: Patients with localized, unfavorable intermediate-risk and high-risk prostate cancer have an increased risk of relapse after radical prostatectomy (RP). The authors previously reported on part 1 of this phase...
9.
Escobar A, Krishna S, Flowers K, Abello A, Gershman B, Wagner A, et al.
J Urol
. 2023 Nov;
211(2):214-222.
PMID: 37984067
Purpose: Transrectal prostate biopsy is a common ambulatory procedure that can result in pain and anxiety for some men. Low-dose, adjustable nitrous oxide is increasingly being used to improve experience...
10.
Baughman C, Mottalib A, Moussa M, Zemany L, Wagner A, Graham K, et al.
Hypertension
. 2023 Oct;
80(12):2501-2505.
PMID: 37830201
No abstract available.